A Rapid Murine Coma and Behavior Scale for Quantitative Assessment of Murine Cerebral Malaria
Open Access
- 1 October 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (10), e13124
- https://doi.org/10.1371/journal.pone.0013124
Abstract
Cerebral malaria (CM) is a neurological syndrome that includes coma and seizures following malaria parasite infection. The pathophysiology is not fully understood and cannot be accounted for by infection alone: patients still succumb to CM, even if the underlying parasite infection has resolved. To that effect, there is no known adjuvant therapy for CM. Current murine CM (MCM) models do not allow for rapid clinical identification of affected animals following infection. An animal model that more closely mimics the clinical features of human CM would be helpful in elucidating potential mechanisms of disease pathogenesis and evaluating new adjuvant therapies. A quantitative, rapid murine coma and behavior scale (RMCBS) comprised of 10 parameters was developed to assess MCM manifested in C57BL/6 mice infected with Plasmodium berghei ANKA (PbA). Using this method a single mouse can be completely assessed within 3 minutes. The RMCBS enables the operator to follow the evolution of the clinical syndrome, validated here by correlations with intracerebral hemorrhages. It provides a tool by which subjects can be identified as symptomatic prior to the initiation of trial treatment. Since the RMCBS enables an operator to rapidly follow the course of disease, label a subject as affected or not, and correlate the level of illness with neuropathologic injury, it can ultimately be used to guide the initiation of treatment after the onset of cerebral disease (thus emulating the situation in the field). The RMCBS is a tool by which an adjuvant therapy can be objectively assessed.Keywords
This publication has 42 references indexed in Scilit:
- Murine cerebral malaria: how far from human cerebral malaria?Trends in Parasitology, 2010
- Algorithms to predict cerebral malaria in murine models using the SHIRPA protocolMalaria Journal, 2010
- The murine cerebral malaria phenomenonTrends in Parasitology, 2009
- Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot studyMalaria Journal, 2009
- Complement factors C1q, C3 and C5 in brain and serum of mice with cerebral malariaMalaria Journal, 2008
- C5 deficiency and C5a or C5aR blockade protects against cerebral malariaThe Journal of Experimental Medicine, 2008
- Protection against cerebral malaria by the low-molecular-weight thiol pantethineProceedings of the National Academy of Sciences, 2008
- Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant miceBMC Genomics, 2007
- Burden, Features, and Outcome of Neurological Involvement in Acute Falciparum Malaria in Kenyan ChildrenPublished by American Medical Association (AMA) ,2007
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005